On the Definition of Sarcopenia in the Presence of Aging and Obesity—Initial Results from UK Biobank. (23rd October 2019)

• Record Type: Journal Article
• Authors: Linge, Jennifer; Heymsfield, Steven B; Dahlqvist Leinhard, Olof
• Editors: Newman, Anne
• Is Part Of: Journals of gerontology. Volume 75:Number 7(2020)
• Page Start: 1309
• Page End: 1316
• Publication Date: 2019-10-23
• Subjects: Sarcopenic obesity -- Muscle fat infiltration -- Magnetic resonance imaging -- Imaging biomarkers -- Dual-energy x-ray absorptiometry; Geriatrics -- Periodicals; Gerontology -- Periodicals; 618.97
• DOI: 10.1093/gerona/glz229
• Languages: English
• ISSNs: 1079-5006

Abstract

Abstract: Background: Current consensus is to combine a functional measure with muscle quantity to assess/confirm sarcopenia. However, the proper body size adjustment for muscle quantity is debated and sarcopenia in obesity is not well described. Further, functional measures are not muscle-specific or sensitive to etiology, and can be confounded by, for example, fitness/pain. For effective detection/treatment/follow-up, muscle-specific biomarkers linked to function are needed. Methods: Nine thousand six hundred and fifteen participants were included and current sarcopenia thresholds (EWGSOP2: DXA, hand grip strength) applied to investigate prevalence. Fat-tissue free muscle volume (FFMV) and muscle fat infiltration (MFI) were quantified through magnetic resonance imaging (MRI) and sex-and-body mass index (BMI)-matched virtual control groups (VCGs) were used to extract each participant's FFMV/height 2 z-score (FFMVVCG ). The value of combining FFMVVCG and MFI was investigated through hospital nights, hand grip strength, stair climbing, walking pace, and falls. Results: Current thresholds showed decreased sarcopenia prevalence with increased BMI (underweight 8.5%/normal weight 4.3%/overweight 1.1%/obesity 0.1%). Contrary, the prevalence of low function increased with increasing BMI. Previously proposed body size adjustments (division by height 2 /weight/BMI) introduced body size correlations of larger/similar magnitude than before. VCG adjustment achieved normalization and strengthened associations with hospitalization/function. Hospital nights, low hand grip strength, slow walking pace, and no stair climbing were positively associated with MFI ( p < .05) and negatively associated with FFMVVCG ( p < .01). Only MFI was associated with falls ( p < .01). FFMVVCG and MFI combined resulted in highest diagnostic performance detecting low function. Conclusions: VCG-adjusted FFMV enables proper sarcopenia assessment across BMI classes and strengthened the link to function. MFI and FFMV combined provides a more complete, muscle-specific description linked to function enabling objective sarcopenia detection.